iGN Biotech Private Limited
© 2026. All rights reserved.
Built on decades of
global expertise
iGN Biotech is building India's first clinical islet transplantation programme on decades of global expertise — spanning transplant surgery, immunology, diabetology and translational science across Oxford, the ICMR and India's leading transplant and diabetes centres.
The founders and board behind iGN Biotech — setting the direction and building India's first clinical islet transplantation programme.
Dr. Nithya Kalyani
Founder & Chief Scientific Officer
Chief Scientist at Rajiv Gandhi Government General Hospital leading the Islet Transplant Program for underserved patients. Former Chief Scientist at Apollo Hospitals with 20+ years in cellular therapies, regenerative medicine, and international collaborations with Oxford and Geneva.
Prem Anand
Chief Executive Officer
Drives iGN's commercialisation roadmap, regulatory navigation, and stakeholder partnerships. Building the bridge between lab breakthroughs and clinical reality.
Dr. Balamurugan Appakalai
Director & Chief Technical Officer
International pioneer in islet cell isolation with 25+ years' experience and 1,500+ human islet isolations. Former faculty at University of Louisville and Cincinnati Children's Hospital.
Global and national scientists guiding islet isolation, immunology and transplantation research.
Practising surgeons and diabetologists advising iGN Biotech on the clinical direction of the programme.
Prof. Dr. Anil Vaidya
Prof. Dr. V. Mohan
Prof. Dr. Dharmarajan
Head, Dept of Diabetology, RGGGH
Ass. Prof. Dr. Pushpa Saravanan
Dept of Diabetology, RGGGH
Dr. Bhuvaneswaran
Director, PSG, Coimbatore
Dr. Praveen
Sparsh Hospitals
Dr. Raghvendra
Sparsh Hospitals
Dr. Elan Kumaran
Liver Transplant Surgeon, Apollo Hospitals
Want to join the mission?
We collaborate with hospitals, research institutions, and clinicians who share our goal of bringing islet transplantation within reach for every patient in India who needs it.